| HOME >> BIOLOGY >> TECHNOLOGY |
Transgenomic, Inc.
Summary Financial Results
Unaudited Condensed Consolidated Statements of Cash Flows
(Dollars in thousands)
Nine Months Ended
September 30,
-------------
2009 2008
---- ----
NET CASH FLOWS PROVIDED BY (USED IN)
OPERATING ACTIVITIES $237 $(472)
NET CASH FLOWS USED IN INVESTING ACTIVITIES (347) (254)
EFFECT OF FOREIGN CURRENCY EXCHANGE RATE
CHANGES ON CASH - (210)
--- ----
NET CHANGE IN CASH AND CASH EQUIVALENTS (110) (936)
CASH AND CASH EQUIVALENTS AT BEGINNING
OF PERIOD 4,771 5,723
----- -----
CASH AND CASH EQUIVALENTS AT END OF PERIOD $4,661 $4,787
====== ======
Transgenomic, Inc.
Summary Financial Results
Condensed Consolidated Balance Sheets
(Dollars in thousands)
(Unaudited)
September 30, December 31,
2009 2008
---- -----
ASSETS
CURRENT ASSETS:
Cash and cash equivalents $4,661
'/>"/>
| SOURCE Transgenomic, Inc. Copyright©2009 PR Newswire. All rights reserved |